Cart
sales@molnova.com
3',4'-Anhydrovinblastine
CAS No. 38390-45-3
3',4'-Anhydrovinblastine( —— )
Catalog No. M18500 CAS No. 38390-45-3
3', 4'-Anhydrovinblastine is an antineoplastic agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 36 | Get Quote |
|
| 25MG | 58 | Get Quote |
|
| 50MG | 86 | Get Quote |
|
| 100MG | 138 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name3',4'-Anhydrovinblastine
-
NoteResearch use only, not for human use.
-
Brief Description3', 4'-Anhydrovinblastine is an antineoplastic agent.
-
Description3', 4'-Anhydrovinblastine is an antineoplastic agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number38390-45-3
-
Formula Weight792.96
-
Molecular FormulaC46H56N4O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCC1=C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Goodbody A, et al. The coupling of catharanthine and vindoline to form 3',4'-anhydrovinblastine by haemoproteins and haemin.[J]. Planta Medica, 1988, 54(03):210-214.
molnova catalog
related products
-
Leptin (150-167) (hu...
Leptin (150-167) (human)
-
3-Isomangostin
3-Isomangostin is an acetylcholinesterase selective inhibitor and a potent human aldose reductase inhibitor with an IC50 of 3.48 uM.
-
Urocortin III, human
Urocortin III (human) is a corticotropin-releasing factor (CRF)-related peptide. Urocortin III (human) preferentially binds and activates CRF-R2 and has a discrete central nervous system and peripheral distribution. Urocortin III (human) selectively binds to type 2 CRF receptors with Ki values of 13.5, 21.7, and >100 nM for mCRF2β, rCRF2α, and hCRF1, respectively. Urocortin III (human) mediates somatostatin-dependent negative feedback control of Insulin (human) secretion.
